News

Parainen Pearl Shipping & Ors v Kristian Gerhard Jebsen Skipsrederi [2018] EWHC 2628 (Pat)11 October 2018Tom Moody-Stuart QC and Lindsay Lane appeared for the Claimants in their claim for a declaration of non-infringement of a patent for a pneumatic cement discharge system. James Abrahams QC, alongside Kathryn Pickard of 11 South Square, appeared for the Defendants. The Claimants own a vessel incorporating a pneumatic cement discharge system in accordance with […]
Unwired Planet v Huawei [2018] EWCA Civ 234423 October 2018Andrew Lykiardopoulos QC, alongside James Segan of Blackstone Chambers, appeared for the Appellants, Huawei. Adrian Speck QC, Isabel Jamal and Tom Jones, alongside Sarah Ford QC of Brick Court Chambers, appeared for the Respondents, Unwired Planet. The appeal was from the decision of Birss J in which he had determined FRAND terms for a global […]
Astex Therapeutics Ltd v AstraZeneca AB [2018] EWCA Civ 24446 November 2018The Court of Appeal upheld the decision of the trial judge in favour of AstraZeneca in relation to a contractual drug development dispute. The parties had engaged in a collaborative research program (the Program) aimed at identifying a drug suitable for inhibiting the BACE enzyme, thought to be involved in the development of Alzheimer’s disease. […]
Actavis and Ors v ICOS & Eli Lilly [2017] EWHC 2880 (Pat)15 February 2018Adrian Speck QC and Tom Jones appeared for Actavis, Teva and Mylan in this application by Lilly and Icos (“Lilly”) for an interim injunction to prevent the launch of generic 2.5 and 5mg tadalafil pending a petition by Lilly to the Supreme Court for permission to appeal. At first instance, Lilly’s patent for a dosing […]
Unwired Planet International Ltd v (1) Huawei Technologies Co. Ltd (2) Huawei Technologies (UK) Co. Ltd5 April 2017Adrian Speck QC, Isabel Jamal and Tom Jones appeared for the Claimant, Unwired Planet, and Andrew Lykiardopoulos QC appeared for the Defendant, Huawei, in a landmark action concerning the nature of a patent holder’s obligations to license Standard Essential Patents (SEPs) on Fair, Reasonable and Non-Discriminatory (FRAND) terms. In a much-anticipated judgment, Birss J found […]